These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35910734)

  • 1. Design and Synthesis of 1-
    Tseng KY; Tzeng ZH; Cheng TR; Liang PH; Hung SC
    Front Chem; 2022; 10():947475. PubMed ID: 35910734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisaccharide Sulfate and Its Sulfonamide as an Effective Substrate and Inhibitor of Human Endo-
    Chiu LT; Sabbavarapu NM; Lin WC; Fan CY; Wu CC; Cheng TR; Wong CH; Hung SC
    J Am Chem Soc; 2020 Mar; 142(11):5282-5292. PubMed ID: 32083852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
    Lamanna WC; Frese MA; Balleininger M; Dierks T
    J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate.
    Pempe EH; Burch TC; Law CJ; Liu J
    Glycobiology; 2012 Oct; 22(10):1353-62. PubMed ID: 22692045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses.
    Oshima K; Han X; Ouyang Y; El Masri R; Yang Y; Haeger SM; McMurtry SA; Lane TC; Davizon-Castillo P; Zhang F; Yue X; Vivès RR; Linhardt RJ; Schmidt EP
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L667-L677. PubMed ID: 31461325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2.
    Panigrahi A; Benicky J; Aljuhani R; Mukherjee P; Nováková Z; Bařinka C; Goldman R
    Mol Cell Proteomics; 2024 Jul; 23(7):100793. PubMed ID: 38825040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin trisaccharides with nonreducing 2-amino-2-deoxy-alpha-D-glucopyranosyl end-groups suitable as substrates for catabolic enzymes.
    Weissmann B; Chao H
    Carbohydr Res; 1986 Oct; 154():217-28. PubMed ID: 3791294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin/heparan sulfate 2-O-sulfatase from Flavobacterium heparinum. Molecular cloning, recombinant expression, and biochemical characterization.
    Myette JR; Shriver Z; Claycamp C; McLean MW; Venkataraman G; Sasisekharan R
    J Biol Chem; 2003 Apr; 278(14):12157-66. PubMed ID: 12519775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.
    Solari V; Borriello L; Turcatel G; Shimada H; Sposto R; Fernandez GE; Asgharzadeh S; Yates EA; Turnbull JE; DeClerck YA
    Cancer Res; 2014 Nov; 74(21):5999-6009. PubMed ID: 25164011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells.
    Yang B; Bhattacharyya S; Linhardt R; Tobacman J
    Biochimie; 2012 Jun; 94(6):1309-16. PubMed ID: 22410212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural diversity of N-sulfated heparan sulfate domains: distinct modes of glucuronyl C5 epimerization, iduronic acid 2-O-sulfation, and glucosamine 6-O-sulfation.
    Safaiyan F; Lindahl U; Salmivirta M
    Biochemistry; 2000 Sep; 39(35):10823-30. PubMed ID: 10978168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional consequences of the subdomain organization of the sulfs.
    Tang R; Rosen SD
    J Biol Chem; 2009 Aug; 284(32):21505-14. PubMed ID: 19520866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
    Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD
    Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human extracellular sulfatases use a dual mechanism for regulation of growth factor interactions with heparan sulfate proteoglycans.
    Timm BM; Follmar JL; Porell RN; Glass K; Thacker BE; Glass CA; Godula K
    bioRxiv; 2023 Nov; ():. PubMed ID: 38045270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases.
    Nishitsuji K
    Glycoconj J; 2018 Aug; 35(4):387-396. PubMed ID: 30003471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells.
    Nawroth R; van Zante A; Cervantes S; McManus M; Hebrok M; Rosen SD
    PLoS One; 2007 Apr; 2(4):e392. PubMed ID: 17460759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein.
    Bame KJ
    J Biol Chem; 1993 Sep; 268(27):19956-64. PubMed ID: 8376358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
    Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
    Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified minimal-size fragments of heparan sulfate as inhibitors of endosulfatase-2 (Sulf-2).
    Kennett A; Epple S; van der Valk G; Georgiou I; Gout E; Vivès RR; Russell AJ
    Chem Commun (Camb); 2024 Jan; 60(4):436-439. PubMed ID: 38086706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.
    Khurana A; Jung-Beom D; He X; Kim SH; Busby RC; Lorenzon L; Villa M; Baldi A; Molina J; Goetz MP; Shridhar V
    Clin Exp Metastasis; 2013 Apr; 30(4):407-15. PubMed ID: 23412907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.